Log in to save to my catalogue

Fabry Cardiomyopathy: Current Practice and Future Directions

Fabry Cardiomyopathy: Current Practice and Future Directions

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_doaj_primary_oai_doaj_org_article_e5beb874f291423db3ac4d4ade4d1230

Fabry Cardiomyopathy: Current Practice and Future Directions

About this item

Full title

Fabry Cardiomyopathy: Current Practice and Future Directions

Publisher

Basel: MDPI AG

Journal title

Cells (Basel, Switzerland), 2021-06, Vol.10 (6), p.1532

Language

English

Formats

Publication information

Publisher

Basel: MDPI AG

More information

Scope and Contents

Contents

Fabry disease (FD) is an X-linked lysosomal storage disorder caused by mutations in the galactosidase A (GLA) gene that result in deficient galactosidase A enzyme and subsequent accumulation of glycosphingolipids throughout the body. The result is a multi-system disorder characterized by cutaneous, corneal, cardiac, renal, and neurological manifest...

Alternative Titles

Full title

Fabry Cardiomyopathy: Current Practice and Future Directions

Authors, Artists and Contributors

Identifiers

Primary Identifiers

Record Identifier

TN_cdi_doaj_primary_oai_doaj_org_article_e5beb874f291423db3ac4d4ade4d1230

Permalink

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_doaj_primary_oai_doaj_org_article_e5beb874f291423db3ac4d4ade4d1230

Other Identifiers

ISSN

2073-4409

E-ISSN

2073-4409

DOI

10.3390/cells10061532

How to access this item